日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial

新型 CDK2/4/6 抑制剂 culmerciclib (TQB3616) 联合氟维司群治疗既往接受过治疗的 HR 阳性、HER2 阴性晚期乳腺癌：一项随机、双盲、3 期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02475-6
Yin, Yongmei; Zhang, Qingyuan; Sun, Tao; Hao, Chunfang; Wang, Zhihong; Yang, Jin; Wang, Yongsheng; Shi, Yanxia; Sun, Jing; Ouyang, Quchang; Su, Haichuan; Wu, Jinsheng; Gan, Lu; Han, Meng; Gao, Liming; Wang, Xiaojia; Zhao, Bing; Li, Hui; Zhao, Jiuda; Yang, Hongwei; Ning, Fangling; Tian, Fuguo; Zhang, Juliang; Sun, Hongmei; Niu, Zhaofeng; Zong, Hong; Zang, Aimin; Wang, Xinshuai; Qian, Xinyu; Wu, Shikai; Nie, Jianyun; He, Lijia; Cheng, Ying; Hao, Yanrong; Zhai, Yi; Li, Huiping; Wang, Jingfen; Wei, Shihong; Li, Man; Liu, Yunjiang; Guo, Hongqiang; Hu, Qun; Liu, Lina; Han, Xinghua; Luo, Ruizhen; Ni, Mingli; Tang, Xianjun; Zhai, Zhenhua; Ding, Meiqian; Wang, Haibo; Shen, Peng; Wang, Xian; Liu, Lian; Chen, Wenyan; Liu, Gang; Cai, Zhengwen; Jiang, Zefei
肿瘤
HER2
肿瘤免疫
乳腺癌
CDK2
发表日期：2025
文献求助 收藏

Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case-Control Study in Chinese Females

LEP和LEPR基因单核苷酸多态性与乳腺癌风险相关：一项针对中国女性的多中心病例对照研究结果

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.809570
Li, Liang; Meng, Xingchen; Liu, Liyuan; Xiang, Yujuan; Wang, Fei; Yu, Lixiang; Zhou, Fei; Zheng, Chao; Zhou, Wenzhong; Cui, Shude; Tian, Fuguo; Fan, Zhimin; Geng, Cuizhi; Cao, Xuchen; Yang, Zhenlin; Wang, Xiang; Liang, Hong; Wang, Shu; Jiang, Hongchuan; Duan, Xuening; Wang, Haibo; Li, Guolou; Wang, Qitang; Zhang, Jianguo; Jin, Feng; Tang, Jinhai; Li, Liang; Zhu, Shiguang; Zuo, Wenshu; Ye, Chunmiao; Yin, Gengshen; Ma, Zhongbing; Huang, Shuya; Yu, Zhigang
肿瘤
LEP
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Erratum: Addendum: Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case-Control Study in Chinese Women

更正：附录：代谢综合征，尤其是高甘油三酯血症-腰围表型，会增加乳腺癌风险，而脂联素可能是其潜在机制：一项针对中国女性的病例对照研究

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2020.00227
Xiang, Yujuan; Zhou, Wenzhong; Duan, Xuening; Fan, Zhimin; Wang, Shu; Liu, Shuchen; Liu, Liyuan; Wang, Fei; Yu, Lixiang; Zhou, Fei; Huang, Shuya; Li, Liang; Zhang, Qiang; Fu, Qinye; Ma, Zhongbing; Gao, Dezong; Cui, Shude; Geng, Cuizhi; Cao, Xuchen; Yang, Zhenlin; Wang, Xiang; Liang, Hong; Jiang, Hongchuan; Wang, Haibo; Li, Guolou; Wang, Qitang; Zhang, Jianguo; Jin, Feng; Tang, Jinhai; Tian, Fuguo; Ye, Chunmiao; Yu, Zhigang
肿瘤
肿瘤免疫
乳腺癌
代谢
代谢综合征
发表日期：2020
文献求助 收藏

Long non-coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes.

长链非编码RNAE330013P06促进2型糖尿病患者的乳腺癌进展

期刊:Journal of Clinical Laboratory Analysis
影响因子:2.9
doi:10.1002/jcla.23172
Chen Runqi, Shi Pengcheng, Zhang Yan, Wu Haiming, Li Xiaoping, Yang Wengfu, Luo Fei, JinmingXue, Yao Liang, Yang Jun, Wang Wangfu, Zhang Bo, Li Peng, Miao Yongmin, Wang Qianjun, Tian Fuguo
代谢
乳腺癌
糖尿病
发表日期：2020
文献求助 收藏

Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case-Control Study in Chinese Women

代谢综合征，尤其是高甘油三酯血症-腰围表型，会增加乳腺癌风险，而脂联素可能是其潜在机制：一项针对中国女性的病例对照研究

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2019.00905
Xiang, Yujuan; Zhou, Wenzhong; Duan, Xuening; Fan, Zhimin; Wang, Shu; Liu, Shuchen; Liu, Liyuan; Wang, Fei; Yu, Lixiang; Zhou, Fei; Huang, Shuya; Li, Liang; Zhang, Qiang; Fu, Qinye; Ma, Zhongbing; Gao, Dezong; Cui, Shude; Geng, Cuizhi; Cao, Xuchen; Yang, Zhenlin; Wang, Xiang; Liang, Hong; Jiang, Hongchuan; Wang, Haibo; Li, Guolou; Wang, Qitang; Zhang, Jianguo; Jin, Feng; Tang, Jinhai; Tian, Fuguo; Ye, Chunmiao; Yu, Zhigang
肿瘤
肿瘤免疫
乳腺癌
代谢
代谢综合征
发表日期：2019
文献求助 收藏

Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)

聚乙二醇化脂质体阿霉素联合环磷酰胺序贯多西他赛作为局部晚期乳腺癌新辅助化疗（注册号：ChiCTR1900023052）

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-019-54387-5
Li, Ruoyang; Tian, Fuguo; Qi, Yixin; Ma, Li; Zhou, Tao; Li, Yuntao; Hui, Tianli; Zhang, Lina; Wang, Shuo; Song, Zhenchuan
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏

Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations

针对中国乳腺癌高遗传风险人群的BRCA基因多中心横断面筛查

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2018.8538
Wei, Hongyi; Wang, Minghao; Ou, Jianghua; Jiang, Weihua; Tian, Fuguo; Sheng, Yuan; Li, Hengyu; Xu, Hong; Zhang, Ruishan; Guan, Aihua; Wang, Changqing; Jiang, Hongchuan; Ren, Yu; He, Jianjun; Liu, Jian; Huang, Weiwei; Liao, Ning; Cai, Xiangjun; Ming, Jia; Ling, Rui; Xu, Yan; Hu, Chunyan; Zhang, Jianguo; Guo, Baoliang; Ouyang, Lizhi; Shuai, Ping; Liu, Zhenzhen; Zhong, Ling; Jing, Ruilin; Zeng, Zhen; Zhang, Meng; Zhang, Ting; Xuan, Zhaoling; Tan, Xuanni; Liang, Junbin; Pan, Qinwen; Chen, Li; Zhang, Fan; Fan, Linjun; Zhang, Yi; Yang, Xinhua; Li, Jingbo; Chen, Chongjian; Jiang, Jun
肿瘤
乳腺癌
肿瘤免疫
发表日期：2018
文献求助 收藏

Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention

体重指数和腰臀比对乳腺癌风险的不同影响，以及雌激素和孕激素受体联合状态的影响：一项来自中国北方和东部的病例对照研究结果及其对化学预防的启示

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2017-0148
Wang, Fei; Liu, Liyuan; Cui, Shude; Tian, Fuguo; Fan, Zhimin; Geng, Cuizhi; Cao, Xuchen; Yang, Zhenlin; Wang, Xiang; Liang, Hong; Wang, Shu; Jiang, Hongchuan; Duan, Xuening; Wang, Haibo; Li, Guolou; Wang, Qitang; Zhang, Jianguo; Jin, Feng; Tang, Jinhai; Li, Liang; Zhu, Shiguang; Zuo, Wenshu; Ma, Zhongbing; Zhou, Fei; Yu, Lixiang; Xiang, Yujuan; Li, Liang; Shen, Shuohao; Yu, Zhigang
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2017
文献求助 收藏

Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients

乌替隆单药治疗或联合卡培他滨治疗既往接受过大量治疗的转移性乳腺癌患者的II期临床试验

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-016-0297-7
Zhang, Pin; Tong, Zhongsheng; Tian, Fuguo; Wang, Yongsheng; Yang, Junlan; Li, Weilian; Di, Lijun; Liu, Wei; Tang, Li; Qiu, Rongguo; Xu, Binghe
肿瘤
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏